We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Sunday
May 08
09:00 - 10:00
Poster Station 2
10: Urology 1
Luca Incrocci, The Netherlands
Poster Discussions are presented at one of the sessions scheduled at the two poster terminals in the exhibition. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be streamed but authors are invited to upload per-recordings for the online platform.
2190
Poster Discussion
Clinical
A new approach to imaging and rapid microbiome identification in prostate cancer patients
Dorota Gabrys, Poland
PD-0407
Long-term outcome after definitive photon vs. combined proton/photon irradiation for prostate cancer
Stefan Alexander Koerber, Germany
PD-0408
Re-irradiation for local recurrence of prostate cancer – results of an international survey
Monica-Emilia Chirilă, Romania
PD-0410
Predictive factors of late GU toxicity after Cyberknife re-irradiation for locally recurrent PCa
Giulio Francolini, Italy
PD-0411
IMPACT OF ADJUVANT RADIOTHERAPY ON BIOCHEMICAL RECURRENCE RATES FOR PN1 PROSTATE CANCER PATIENTS
Giulia Corrao, Italy
PD-0412
Outcomes in pelvic versus common iliac node positive prostate cancer treated with curative RT
PRADNYA CHOPADE, India
PD-0413
Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer
Cesare Cozzarini, Italy
PD-0414
Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms
Cesare Cozzarini, Italy
PD-0415
Derivation and external validation of a RAPID Risk score for predicting significant prostate cancer
Max Peters, The Netherlands
PD-0416
Planned total duration of triptorelin treatment in patients with prostate cancer, TALISMAN study
Gilles Crehange, France
PD-0417
Resect or Preserve? Comparing treatment strategies in clinically node positive bladder cancer
Martin Swinton, United Kingdom
PD-0418